According to PTC Therapeutics
's latest financial reports the company's current revenue (TTM ) is C$1.16 Billion. a decrease over the revenue in the year 2023 that were of C$1.24 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | C$1.15 B | -6.93% |
2023 | C$1.24 B | 31.18% |
2022 | C$0.94 B | 38.15% |
2021 | C$0.68 B | 41.38% |
2020 | C$0.48 B | 21.09% |
2019 | C$0.40 B | 11.18% |
2018 | C$0.36 B | 47.55% |
2017 | C$0.24 B | 119.9% |
2016 | C$0.11 B | 104.13% |
2015 | C$54.44 M | 104.31% |
2014 | C$26.64 M | -20.08% |
2013 | C$33.34 M | 16.52% |
2012 | C$28.61 M |